Login / Signup

UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis.

Giuseppina AbignanoGianna Angela MennilloGiovanni LettieriDuygu Temiz KaradağAntonio CarrieroAngela Anna PadulaFrancesco Del GaldoZsuzsanna H McMahanSalvatore D'Angelo
Published in: The Journal of rheumatology (2021)
SSc patients with impaired ETS findings have a higher GIT 2.0 reflux score. The GIT 2.0 is a complementary tool for objective measurement of esophageal involvement that can be easily administered in day-to-day clinical assessment.
Keyphrases
  • systemic sclerosis
  • interstitial lung disease
  • clinical trial
  • transcription factor
  • randomized controlled trial
  • rheumatoid arthritis
  • open label
  • double blind